Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    Open Studies | "Hypotrichosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypotrichosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan
Condition: Eyelash Hypotrichosis
Intervention: Drug: Bimatoprost cutaneous solution 0.03%
2 Not yet recruiting Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: PF-06651600;   Drug: PF-06700841;   Drug: Placebo
3 Recruiting Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
Condition: Alopecia
Interventions: Drug: CG 428 cutaneous solution;   Drug: Placebo cutaneous solution
4 Recruiting Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study
Condition: Androgenic Alopecia
Interventions: Device: ARTAS System;   Other: Manual Implantation
5 Not yet recruiting Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia
Condition: Hair Restoration Using Autologous Mesenchymal Stem Cells
Interventions: Drug: stem cells;   Drug: platelet rich plasma
6 Recruiting Hairstetics Hair Implant Device Safety and Efficacy
Condition: Alopecia
Intervention: Device: Hairstetics hair implant device
7 Not yet recruiting Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
Condition: Androgenic Alopecia
Interventions: Drug: DA-4001 H;   Drug: DA-4001 L
8 Recruiting Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention: Drug: Tofacitinib ointment
9 Recruiting "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
Condition: Chemotherapy-induced Alopecia
Intervention: Behavioral: Semi-structured interviews
10 Recruiting Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Condition: Alopecia
Interventions: Drug: setipiprant;   Drug: placebo;   Drug: finasteride
11 Recruiting Point-of-Care Adipose-derived Cells for Hair Growth
Condition: Androgenetic Alopecia
Interventions: Procedure: Stromal Vascular Fraction Cells (SVF Cells) Injection;   Procedure: Liposuction;   Other: Hair Measurements
12 Recruiting Topical Garlic Concentrate for Alopecia Areata in Children
Condition: Alopecia Areata
Intervention: Drug: garlic concentrate
13 Recruiting Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Apremilast;   Drug: Placebo
14 Recruiting A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Tralokinumab;   Drug: Placebo
15 Recruiting Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Conditions: Alopecia;   Alopecia, Androgenetic;   Baldness
Intervention: Drug: Bimatoprost
16 Not yet recruiting Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: SHAPE Gel
17 Recruiting Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
Condition: Alopecia Areata
Intervention: Other: MEXIS/M6S Patent - lotion against alopecia
18 Recruiting A Study of Secukinumab for the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Secukinumab;   Drug: Placebo
19 Not yet recruiting Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment
Condition: Androgenetic Alopecia
Interventions: Device: Autologous Platelet Rich Plasma;   Device: Saline solution injection
20 Recruiting LEO 124249 Ointment in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: LEO 124249;   Other: Vehicle

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.